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Introduction {#s0005}
============

Historically, upper tract (UT) recurrence after radical cystectomy (RC) for urothelial carcinoma (UC) has been reported in 2--22% of cases [@b0005], [@b0010], [@b0015], [@b0020] and these patients, due to multiple reasons, tend to have poorer prognosis compared to those with primary UT-UC [@b0015], [@b0025], [@b0030], [@b0035]. Multiple tumour-related factors for UT recurrence have been identified including tumour grade, stage, multifocality, history of carcinoma *in situ* (CIS) in the RC specimen, prostatic urethral involvement, and the presence of distal ureteric involvement with CIS [@b0005], [@b0040], [@b0045], [@b0050], [@b0055], [@b0060], [@b0065]. The incidence of positive distal ureteric margins (PUM) at RC ranges from 2% to 35% [@b0070]. However, despite the fairly high incidence of PUM, the clinical significance of PUM at RC, as well as the role of intraoperative frozen section analysis (IFSA), is still under debate.

In our institute, we do not perform IFSA routinely, but rely on gross examination of the distal ureter. We planned to retrospectively analyse our data in order to identify tumour-related factors at initial transurethral resection of bladder tumour (TURBT) that would predict PUM, so that patients with risk factors may be selectively offered IFSA.

Patients and methods {#s0010}
====================

Study design, setting and patients {#s0015}
----------------------------------

After approval from the Institutional Review Board, we retrospectively reviewed the electronic record database of our institute from June 2007 to June 2016. Patients who underwent TURBT and subsequently RC for non-metastatic UC of the bladder were identified. The following variables were recorded: age; sex; history of use of tobacco; history of intravesical BCG or neoadjuvant chemotherapy; clinical TNM stage; presence of hydroureteronephrosis; and primary pathological tumour features (on initial TURBT) including maximum size, multifocality, location in the bladder, stage and grade of tumour, presence of CIS, and/or other adverse histology. Patients with metastatic disease who underwent palliative RC, those with concomitant UT-UC or suspected to have UT-UC preoperatively were excluded. Data for 211 patients were available for analysis.

Surgical and pathological technique {#s0020}
-----------------------------------

Open RC with extended pelvic lymphadenectomy was performed according to the standard technique in all patients. Either an ileal conduit or ileal neobladder were performed for urinary diversion. The pros and cons of both options were discussed with the patients and the decision on the type of diversion was primarily influenced by the patient's age and comorbidities.

Most of the patients underwent an ileal conduit diversion, whilst only a few had an ileal neobladder. Ureters were transected at the level of or just below the iliac vessels, and visual assessment of the distal ureteric margins was carried out. IFSA was performed in only eight patients.

On histological examination of the RC specimen, ureteric margins were histologically classified as positive (involved) or negative (uninvolved). Ureteric margins with urothelial malignancy, CIS, high-grade atypia or dysplasia were classified as positive, i.e. PUM. This was correlated to the collected preoperative variables including pathological features of primary tumours at initial TURBT.

Statistical methods and analysis {#s0025}
--------------------------------

All analyses were done using STATA 13.1/IC statistical software (Stata Corporation, College Station, TX, USA). Data were summarised as mean (SD) or median (range) for continuous variables, and frequency with percentage for categorical variables. For the purpose of analysis, we divided our cohort into two groups: Group-I comprised patients who had PUM, and the Group-II patients had negative distal ureteric margins. Both groups were compared for all the collected variables. Univariate relationships were studied using chi-squared statistics for categorical variables, and independent *t*-test/Mann--Whitney *U* test for continuous variables. Multivariate logistic regression was performed to examine the adjusted effects of different variables, so as to determine the predictors of PUM.

Results {#s0030}
=======

Data from 211 patients who underwent TURBT and subsequently RC with ileal conduit (172 patients) or ileal neobladder (39 patients) for UC of bladder from June 2007 to June 2016 were included in the analysis. Seventeen (8.1%) patients had PUM (Group-I), whilst 194 had negative ureteric margins (Group-II) on RC specimen. Both groups were comparable for age and sex distribution, although Group-I had significantly more patients with a history of tobacco use ([Table 1](#t0005){ref-type="table"}). All patients in this cohort had high-grade UC on initial TURBT.Table 1Patients' demographic and tumour-related characteristics.VariableGroup-I\
PUMGroup-II\
Negative ureteric margin*P*Number of patients17194Male: female14: 3176:180.73  Age, years0.64 Mean (SD)54.4 (11.5)53 (10.1) Median (range)51 (42--77)55 (30--81)0.54Maximum size of tumour, cm, mean (SD)5.8 (2.7)5.11 (1.9)0.71  *N* (%): History of smoking/tobacco use13 (81)107 (55)0.015 Presence of hydroureteronephrosis9 (56.3)86 (44.3)0.36 Multifocal tumours8 (47.0)42 (21.6)0.04[\*](#tblfn1){ref-type="table-fn"} Tumour involving the ureteric orifice(s)14 (87.5)74 (38.1)0.002[\*](#tblfn1){ref-type="table-fn"} Trigone involvement10 (58.8)70 (36.1)0.04[\*](#tblfn1){ref-type="table-fn"} Prior BCG or chemotherapy1 (6.3)40 (20.6)0.19  Pathological stage and grade on TURBT pT1HG4 (23.5)59 (30.4)0.43 pT2HG10 (58.8)127 (65.4)0.48 pTaHG3 (17.6)8 (4.1)0.034 Presence of CIS at TURBT8 (47.0)32 (16.5)0.03[\*](#tblfn1){ref-type="table-fn"} Presence of LVI at TURBT4 (23.5)11 (5.7)0.04[\*](#tblfn1){ref-type="table-fn"}  Other adverse histology\
-- Sarcomatoid/squamous/glandular7 (43.8)56 (28.9)0.35[^1][^2]

Of the 211 patients, 44 (20.8%) underwent RC for non-muscle-invasive bladder cancer. The majority of them had BCG-refractory cancer.

Both groups were similar in terms of mean maximum size of the tumour and presence of hydroureteronephrosis. Multifocal tumours were more commonly associated with PUM than those with negative ureteric margins (*P* = 0.04). Patients with tumours involving the ureteric orifice and those located over the trigone were found to have a significantly greater chance of having PUM at final histology. A prior history of intravesical BCG or neoadjuvant chemotherapy was not found to be associated with PUM. Further analysis revealed that presence of CIS and lymphovascular invasion (LVI) at TURBT were significantly more common in Group-I. However, associated adverse histological features were equally distributed between the groups ([Table 1](#t0005){ref-type="table"}).

On multivariate analysis, the factors that were found to be significant predictors of PUM included: history of tobacco use (odds ratio \[OR\] 12.90, 95% CI 10.6--15.2; *P* = 0.003), involvement of the ureteric orifice(s) by the tumour (OR 16.28, 95% CI 13.2--19.4; *P* = 0.001), and presence of associated CIS (OR 9.42, 95% CI 8.4--10.5; *P* = 0.002). After adjustment for other factors no associations were found for trigone involvement, multifocality and presence of LVI with PUM (*P* \> 0.1) ([Table 2](#t0010){ref-type="table"}).Table 2Multivariate analysis to determine the effect of various factors on PUM.FactorsOR (95% CI)*P*History of smoking/tobacco use12.90 (10.6--15.2)0.003[\*](#tblfn2){ref-type="table-fn"}Involvement of the ureteric orifices16.28 (13.2--19.4)0.001[\*](#tblfn2){ref-type="table-fn"}Presence of CIS at TURBT9.420 (8.4--10.5)0.002[\*](#tblfn2){ref-type="table-fn"}Trigone involvement at TURBT2.45 (1.35--3.55)0.155Presence of LVI at TURBT1.37 (0.83--1.9)0.763Multifocal tumours at TURBT0.66 (0.2--1.0)0.88Prior BCG0.58 (0.3--0.8)0.64Hydroureteronephrosis0.97 (0.81--1.13)0.531[^3]

In the present cohort, only eight patients underwent IFSA. All of them had gross involvement of ureteric orifice(s). Only two of them showed abnormality. One of them was converted to a negative ureteric margin after sequential sectioning and repeat IFSA. In the other case, an additional length of ureter was excised but further confirmation of a negative ureteric margin by repeat IFSA was not done. On final histology, the distal ureteric margin was negative in the first case; but revealed high-grade dysplasia in the second case. In the remaining six cases, distal ureteric margins were uninvolved on both IFSA and final histology.

Discussion {#s0035}
==========

The incidence of UT recurrence after RC is quite low (3.4%) in most contemporary series [@b0075]. PUM at RC and UT recurrence later are likely to be driven by adverse features related to the primary bladder lesion. The chances of UT recurrence after RC are higher if the distal ureteral margin is positive (especially if CIS is found) [@b0055], [@b0080], [@b0085]. To reduce UT recurrences, IFSA was suggested, in order to detect PUM and ensure conversion to a negative ureteric margin. However, the routine use of IFSA in all patients during RC has been questioned. Although, IFSA can detect distal ureteric involvement with reasonable accuracy [@b0055], [@b0090], [@b0095], high false-positive rates of up to 44% result in overestimation of disease at the distal ureteric margin [@b0095]. Other issues associated with IFSA include practicality, cost-effectiveness, and increased operative time [@b0100], [@b0105]. Thus, the risk--benefit ratio of routine IFSA is unlikely to be favourable, and a balanced and patient-specific implementation of IFSA is required.

However, risk factors for PUM and UT recurrence identified to date are based on final RC. Therefore, patients who have higher risk of PUM could be selectively offered IFSA if we can identify them based on primary tumour-related factors (at TURBT itself). If an abnormality is detected, the clinician may like to keep the patient on even more frequent screening. A recent study by Tollefson et al. [@b0080] has shown that patients who undergo conversion to a negative final ureteric margin with IFSA and serial sectioning of the distal ureter have a reduced risk of UT recurrence. In their retrospective cohort of 1397 patients, IFSA was performed in all patients. Initial PUM was detected in 12.7%, and final resection PUM in 2.2% of patients. Amongst initial PUM, 82.6% were converted to a negative final margin. However, in a series by Gakis et al. [@b0090] conversion to a negative final ureteric margin was not possible in \>50% of cases despite multiple re-resections.

Moschini et al. [@b0110] have recently reported the only study to date (largest single centre European cohort, 1447 patients) that has shown that achieving negative ureteric margins by IFSA may be associated with survival benefit. However, this was seen amongst patients who had no residual cancer on RC specimen.

Almost all reported data related to the issue of distal ureteric margins are from series that incorporated IFSA. In the present series, ureteric transection was performed at the level of iliac vessels in all patients, and a routine IFSA was not performed. The PUM rate in the RC specimens was 8.1%. It is important that despite not performing routine IFSA in our present series, the incidence final PUM was low and similar to previous reports [@b0095]. This indicates that further studies with larger number of patients are needed to clarify whether or not IFSA actually reduces final PUM. Nevertheless, our present study identified primary tumour-related factors at TURBT, which predict PUM at RC and consequently patients could be selectively offered IFSA who might be benefited.

Our present study is retrospective with its attendant limitations. The number of patients in our present study was relatively fewer than in other studies. Further, it does not provide evidence for a relationship between PUM and UT recurrence. However, owing to the rare occurrence of PUM and even rarer that of UT recurrence, prospective studies with large numbers cannot be expected in near future.

Conclusions {#s0040}
===========

The incidence of PUM following RC is low. On TURBT, the primary tumour-related factors that predicted PUM (at RC) in the present study were involvement of the ureteric orifice(s) by the tumour, and presence of associated CIS. Our present results may help to identify patients who can be selectively offered IFSA.
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[^1]: HG, high grade.

[^2]: *P* \< 0.05.
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